Author: trainitright

Review: Growing Consensus that the Right Kinds of Brain Training Work

SAN FRANCISO – August 6, 2018 – A new review article tackles the competing headlines on the efficacy of brain training, looking across the data, and finding a growing consensus that computerized cognitive training has benefits.  Much of the compelling evidence that brain training is effective in older adults comes from studies of exercises found only in the app BrainHQ from Posit Science.

The review, in the current issue of Biological Psychiatry: Cognitive Neuroscience and Neuroimaging focuses on the four largest studies of brain training in older adults and on the most recent and comprehensive meta-analyses of studies on cognitive training and aging. The review is authored by an international team of leading researchers in the field of cognitive training, including authors from the University of Miami, King's College London, Boston University, and Posit Science.

“Four large randomized controlled trials and multiple meta-analyses have found consistent evidence that CCT [Computerized Cognitive Training] improves cognitive performance and real-world function in healthy older adults,” the authors write. They go on to note that not all cognitive training is the same and that different approaches “have distinct effects.”

The four largest studies collectively enrolled 6,921 subjects, and all showed improvements in standard cognitive measures, as well as in measures of real world function. Interestingly, one of those studies was a follow-on report to a study first published in 2010 in Nature, which initially got wide coverage for reporting no impact from cognitive training; however, when the data for older adults was examined and published five years later, the same research team reported significant impact in older adults in standard measures of both cognition and maintaining real-world independence. That shift in outcomes mirrors a growing consensus in the medical community.

In 2015, the Alzheimer’s Association found “sufficiently strong evidence” that risk of cognitive decline could be reduced through lifestyle changes, including physical exercise, management of cardiovascular risk, diet, and cognitive training. In 2017, the National Academies of Sciences, Engineering and Medicine reported three recommendations for people who want to be proactive about their brain health: brain exercise, physical exercise and hypertension medicine (if blood pressure is too high). In December 2017, the American Academy of Neurology advised physicians that they can recommend cognitive training to patients with Mild Cognitive Impairment.

“When reading the history of science, it often seems that a paradigm shift is driven by a single breakthrough experiment that convinces everyone that a new way of thinking is correct.,” observed Dr. Henry Mahncke, CEO of Posit Science and co-author of the review. “However, as someone who is working daily on the front lines of such a paradigm shift, I can tell you that it is the step-by-step accumulation of evidence from large studies and careful evidence reviews that drives that new paradigm. Regarding brain training, that evidence has come in over the past several years, and as a result the clinical consensus is now catching up.”

Britannia Pharmaceuticals Ltd: Phase 3 TOLEDO Study Shows Apomorphine Infusion Provides Effective Relief of Persistent Motor Fluctuations in Parkinson's Disease (PD) Patients Whose Symptoms are Uncontrolled With Oral Medication

 

LONDON, Aug. 3, 2018 /CNW/ - Britannia Pharmaceuticals Ltd has announced publication of the results of the double-blind phase of the TOLEDO study in Lancet Neurology[1].

Treatment with APO-go®/MOVAPO® (apomorphine) subcutaneous infusion for 12 weeks gave significantly greater reductions in OFF time (periods when PD medications don't work) from baseline compared with placebo: -2.47 h/day versus -0.58 h/day, respectively - a treatment difference of almost 2 hours (p=0.0025) and double the change in OFF time recognised as meaningful to PD patients. These reductions were seen in the first week of treatment with APO-go®/MOVAPO® infusion.

Compared with placebo, significantly greater increases in ON time (periods with good motor control) without troublesome dyskinesia - 'good' ON time - from baseline were observed with APO-go®/MOVAPO® infusion: 2·77 h/day versus 0·80 h/day, respectively (p=0·0008), and patients could also reduce the dosage and number of administrations of concomitant oral PD medications significantly (p=0.0014).

APO-go®/MOVAPO[®/] infusion is an established therapy for PD, a disease characterised by progressive degeneration of dopamine-containing neurons in the brain, resulting in loss of motor control. TOLEDO is the first multicentre, randomised, double-blind trial to investigate its efficacy and safety in PD and was undertaken in 107 patients from 23 hospitals in 7 countries whose symptoms were uncontrolled despite taking multiple medications.

Clinical improvements were reflected in patients' assessment of treatment: significantly more APO-go®/ MOVAPO® infusion patients rated themselves as 'improved' (71%) versus placebo (18%; p<0.0001).

Professor Regina Katzenschlager, lead investigator of TOLEDO, commented:

"TOLEDO is an important addition to our knowledge, providing Level 1 evidence for the first time and confirming previous observational studies. Apomorphine infusion is effective and well tolerated by patients experiencing debilitating treatment response fluctuations despite optimised treatment."

Professor Andrew Lees, an investigator in the pivotal clinical trial that led to apomorphine being licensed for PD treatment in the UK, added:

"We hope the positive results of the TOLEDO study will help ensure apomorphine infusion, which is delivered using a small, ambulatory mini-pump, is incorporated into national PD treatment guidelines."

The TOLEDO study is sponsored by Britannia Pharmaceuticals Ltd., part of the STADA Arzneimittel AG group of companies and manufacturer of apomorphine products.

Founded in 1982, Britannia Pharmaceuticals Limited is a pharmaceutical company based in Reading, UK, specialising in the neurology market.

Britannia is owned by Frankfurt-based STADA Arzneimittel AG.

APO-go® products are marketed in the UK by Britannia Pharmaceuticals Ltd and transferred with the acquisition of Britannia into the STADA portfolio in 2007. APO-go® products are marketed outside the UK through own affiliates and licensing partners.

For information about:

Britannia Pharmaceuticals Ltd:

http://www.britannia-pharm.com

TOLEDO study:

https://www.clinicaltrials.gov/ct2/show/NCT02006121?term=NCT02006121&rank=1

For the APO-go® infusion SmPC:

https://www.medicines.org.uk/emc/product/3908/smpc

[1]Katzenschlager R, et al. Lancet Neurology, 2018. Published online July 25, 2018 http://dx.doi.org/10.1016/S1474-4422(18)30239-4

SOURCE Britannia Pharmaceuticals Ltd.

martha1.jpgMarthaSkin.jpg

 

From Breathing Difficulty to Breathless Transformation,

How A Canadian Mother Defined Odds to Overcome Her Personal Struggle and Weight loss Journey

 

Canadian mother, Martha Melanie, reveals how she lost 45 pounds in just three months, despite going through personal hardship and ongoing medical issues that were significantly impacting on her lifestyle. Martha was able to shed weight fast, by following a simple, clean eating dietary plan, combined with a lifestyle reevaluation and monitoring.

Having lifelong experiences of weight fluctuation, Martha had always had goals to jumpstart her weight gain, such as her destination wedding. Once her mother passed away in 2015, all motivation was lost and Martha began to downward spiral. She was eating all the time to cope with her sadness and gained upwards of 33 pounds. Soon, the weight gain was accompanied with joint pain and headaches, leading to several other health issues.

Martha recounts on her previous struggles with weight gain over the years. When it had gotten its worse, Martha shared “my daughter told me that I stopped breathing in the middle of the night”. Martha claims, “I remembered having to hold the rail and slow down because I was wheezing and a bit of out of breath. I found myself becoming low on energy every day and feeling pain in my joints in the lower part of my body.” After these instances, Martha decided to take a hard look at her life and make some serious changed, or else she was scared she wouldn’t make it to her 50th birthday.

Along with 123Diet and a controlled meal plan, Martha claims staying focused and ultimately keeping her eyes on the prize helped her achieve her weight-loss goals. But that doesn’t mean she had to withdraw from her favorite foods.

“I started to lose weight and my self-confidence started to change. I made sure I follow everything well.  Soon my clothes starting to get a bit looser and it motivated me to continue. I got excited and started to take pictures every weekend!”. The struggling mother has now not only transformed her body, but also her life. Ms Melanie has expressed her past emotions toward her body image and how 123Diet has changed her outlook completely, also whilst allowing her to combat her health issues full frontal.

Martha thanks her change in diet, hard work and determination for her new and healthy lifestyle.

“This diet is amazing and suits my life style. I know as you get older it is harder to lose weight, but this diet works magically. I cannot believe at soon to be 50 years old, I will feel like a 25-year-old. I went from the size XL/1X to S. and size 14/16 to size 6. I still have about 11 pounds more to go before my final goal weight,” the mother said.

“To date I am very happy with my determination despite some little ups and downs. I wake up positively every day.”

Sectra Signs new Enterprise-Wide PACS Contract With Academic Health System

 

SHELTON, CT, Aug. 2, 2018 /CNW/ - International medical imaging IT and cybersecurity company Sectra (STO: SECT-B) will install its enterprise imaging PACS throughout Stanford Health Care (SHC) and Lucile Packard Children's Hospital to support clinical and research imaging needs of the organization. The Sectra solution - integrated with Epic Radiant - will ensure business continuity, high system availability, and scalability for future growth.

In addition to Sectra PACS for all diagnostic radiology, the multi-year agreement will include advanced visualization tools, teaching file software, Sectra Breast Imaging PACS for mammography workflow, 2D and 3D orthopaedic templating tools, business analytics and a universal viewer. Stanford Health Care is part of Stanford Medicine, an academic health system that includes the Stanford University School of Medicine, Stanford Health Care, and Stanford Children's Health, with Lucile Packard Children's Hospital.

"On behalf of the 700 employees at Sectra, we are delighted to work with a prestigious institution such as Stanford Health Care. We look forward to exceeding their expectations and collaborating on future research endeavors," says Mikael Anden, President of Sectra, Inc.

Sectra PACS is optimized for high production environments and designed to shorten report turnaround times, enhance result distribution workflows, and improve communication between radiology and referring departments. For five continuous years in the US, Sectra PACS has won the customer satisfaction award 'Best in KLAS' for large hospitals.

About Sectra

With more than 25 years of innovation and 1,800 installations worldwide, Sectra is a leading global provider of imaging IT solutions that support healthcare in achieving patient-centric care. Sectra offers an Enterprise Image Management solution comprising PACS for imaging-intense departments (radiology, pathology, cardiology and orthopedics), VNA, and share and collaborate solutions. Read more about Sectra and why Sectra PACS is 'Best in KLAS' for a fifth consecutive year at http://www.sectra.com/medical/.

SOURCE Sectra, Inc

Health and Fitness Travel Launches New Website

 

 

Health and Fitness Travel, the wellness holiday specialists has released their all-new global website. Substantial revamps have led to improved aesthetic design, better accessibility and an intuitive layout, providing optimal navigation and even more resources for customers looking for a wellness holiday.

 

With the UK and Australian websites becoming international and advanced filtering of holidays, the consumer experience has improved exponentially.

 

Paul Joseph, co-founder of Health and Fitness Travel says “We continually strive to evolve and provide the best service possible and expand our offerings to the diversifying needs of our clients. Having a global-friendly website allows us to spread our passion for travel and well-being, placing us one step closer to achieving our mission of improving the lives of 100,000 wellness travellers by 2028.”

 

To achieve their mission, the global team, with headquarters in London, Melbourne, Manila and Toronto, are working hand in hand with partners, sharing accumulated knowledge and expertise, journeying far and beyond to seek new experiences they know their clients will love.

 

To experience the new Health and Fitness Travel website for yourself visit www.healthandfitnesstravel.com

 

Explore Health and Fitness Travel’s latest holidays, featured on the new website:

 

Pine Cliffs, Portugal

 

Set atop the scenic Algarve cliffs overlooking the Atlantic Ocean, Pine Cliffs is a secluded haven that provides a well curated luxury holiday. The resort is beautifully designed, adorned with murals and hand painted tiles that exhibit the richness of Portuguese culture. Be as relaxed and pampered as you wish with lavish spa treatments or active and on the go as you enjoy a broad range of fitness facilities and outdoor activities. For those wanting to enjoy the sun, sand and sea, venture a little further via panoramic lift and boarded walkway to the pristine Falésia Beach.

 

Health and Fitness Travel (0203 397 8891 healthandfitnesstravel.com) offers 6 nights at Pine Cliffs from £1,985pp or £2,905 for single occupancy. Price includes full board, a wellness programme and return private transfers.

 

The Retreat Costa Rica, Costa Rica

 

A private haven perched on the sloping hillside of a quartz mountain, The Retreat Costa Rica exudes intimacy and calm with just 11 rooms. This transformational retreat was founded by life coach, celebrity chef and best-selling author Diana Stobo to provide a place that epitomizes well-being and promote a natural approach to addressing health issues. Through its six core tenets of stress reduction, cultural involvement, gentle physical activity, spiritual connectedness, wellness recovery and organic eating, embark upon a journey that will lead you to a balanced and healthy lifestyle.

 

Health and Fitness Travel (0203 397 8891 healthandfitnesstravel.com) offers 4 nights at The Retreat from £1,040pp or £1,295 for single occupancy. Price includes full board, a wellness programme and return private transfers.

 

Svarga Loka, Bali

 

Set on the riverbanks of the spiritual Campuhan river in Ubud, Svarga Loka caters to the discerning needs of wellness travelers, providing a sacred place to reflect and rejuvenate. With various programs and visiting international experts, focus on any wellness goals, from mindfulness, weight management to detox and holistic healing. Experience luxury accommodation and a range of activities including yoga, meditation, workshops and spa therapies. Svarga Loka not only offers a tranquil sanctuary, but also provides guests with invaluable skills and knowledge to continue their transformation journey long after their stay.

 

Health and Fitness Travel (0203 397 8891 healthandfitnesstravel.com) offers 5 nights at Svarga Loka from £1,750pp or £2,190 for single occupancy. Price includes full board, a wellness programme and return private transfers.

 

Quintessence Retreats, France

 

Journey to the enviable address of Courchevel, located at the heart of the French Alps in the world’s largest ski area, for a unique fitness journey with a touch of luxury. This retreat espouses an active lifestyle through a combination of sports, functional fitness, nutrition, and an atmosphere of an exceptionally beautiful environment. After every action-packed session, head to the social dining area to refuel with a healthy meal, prepared by in-house chefs. Bathe in the cool, crisp mountain air as you explore the serene surroundings and later end the day with a rebalancing yoga and meditation class.

 

Health and Fitness Travel (0203 397 8891 healthandfitnesstravel.com) offers 7 nights at Quintessence from £2,665pp or £2,580 for single occupancy. Price includes breakfast, a wellness programme and return private transfers.

 

Baobab Suites, Tenerife

 

A fusion of luxury and minimalism, Baobab Suites boasts elegant apartments with floor-to-ceiling windows and efficient facilities perfect for your all wellness pursuits. This retreat follows a well-balanced approach to wellness with active fitness sessions and soothing wellness and aesthetic treatments for recovery and relaxation. Practice various forms of yoga, tone up with Pilates or boost your endurance with swimming and running with expert coaching. Throughout the day and evening, enjoy nutritious meal options to reinvigorate your body. For those who want to explore, this island escape is just a walk away from beautiful beaches and close to buzzing shopping centres.

 

Health and Fitness Travel (0203 397 8891 healthandfitnesstravel.com) offers 5 nights at Baobab Suites from £720pp or £1,205 for single occupancy. Price includes breakfast, a wellness programme and return private transfers.

 

Macdonald Monchique Resort and Spa, Portugal

 

Nestled between lush pine forests and stunning mountains, Macdonald Monique exudes modern elegance harmonised with classic Portuguese flair. This health retreat puts your well-being at the front and centre with facilities and programs that help you find inner balance and self-awareness. For a unique pampering experience, unwind in the sensorial spa thermal circuit along with a range of treatments inspired by nature. Along with daily fitness activities, a range of healthy gastronomic experiences and luxurious accommodation appointed with unspoiled views of the sea and mountains, this hidden spa retreat checks all the boxes for a truly remarkable holiday.

 

Health and Fitness Travel (0203 397 8891 healthandfitnesstravel.com) offers 7 nights at Macdonald Monchique from £1,015pp or £1,245 for single occupancy. Price includes full board, a wellness programme and return private transfers.

 

Wildfitness Menorca, Spain

 

Feel the freedom of nature as you escape to the Balearic island of Menorca for an exhilarating fitness and wellness retreat. Share a life changing fun-filled adventure with like-minded individuals amidst an untouched Mediterranean coastline and surrounded by beautiful fauna. This back to nature break will leave your body charged and mind de-stressed with a plethora of outdoor activities, from sunrise yoga and circuit training to restorative stretching and massages. Combining luxe-living, exercise, mindfulness and nutrition, Wildfitness Menorca promises an all-encompassing approach to health and fitness.

 

Health and Fitness Travel (0203 397 8891 healthandfitnesstravel.com) offers 6 nights at Wildfitness Menorca from £1,210pp or £1,725 for single occupancy. Price includes full board, a wellness programme and return private transfers.

 

Borgo Egnazia, Italy

 

Set in a rural castle in beautiful Puglia, Italy, Borgo Egnazia finds itself quietly removed from the frantic buzz of city life. Experience wellness in the lap of luxury with private fitness sessions, lavish spa treatments and a healthy gastronomy for the senses. Following a holistic approach, indulge in an extensive list of natural body care therapies to soothe you into deep relaxation. The retreat boasts 184 rooms, which spread throughout their grounds, multiple restaurants to suit any taste buds and an array of health and wellness facilities to accommodate a wealth of complimentary activities.

 

Health and Fitness Travel (0203 397 8891 healthandfitnesstravel.com) offers 5 nights at Borgo Egnazia from £1,795pp or £2,335 for single occupancy. Pricing includes breakfast, a wellness programme and return private transfers.

 

Six Senses Kaplankaya, Turkey

 

Six Senses Kaplankaya is a secluded wellness sanctuary set by the picturesque southern Aegean coast. Embrace a ‘live younger, longer’ attitude as you give your health a boost with a selection of indulgent spa treatments and fitness activities. Disengage from the stresses of daily life as you find your calm with sunrise yoga or a morning coastal walk, then sweat it out on a personal training session that will put you through your paces. Whatever your goals are, this Turkish getaway is guaranteed to help you take a step back and focus on your well-being.

 

Health and Fitness Travel (0203 397 8891 healthandfitnesstravel.com) offers 7 nights at Six Senses Kaplankaya from £2,485pp of £3,530 for single occupancy. Price includes breakfast, a wellness programme and return private transfers.

 

The BARAI Spa, Thailand

 

The award-winning BARAI Spa is the ideal destination for an all-encompassing healthy break to unwind and de-stress. Situated over acres of spectacular white sand beach, the BARAI is naturally centered on the element of water, bringing rejuvenation and healing by combining traditional Thai health rituals with contemporary western approaches. In this pocket of paradise, stay in a stunning BARAI spa suite with the luxury of your own private concierge. Whether you wish to practice yoga, kick-start your fitness or simply relax with holistic spa treatments, The BARAI has you covered.

 

Health and Fitness Travel (0203 397 8891 healthandfitnesstravel.com) offers 7 nights at The BARAI Spa from £2,335pp or £3,420 for single occupancy. Price is full board, with a bespoke programme and return private transfers.

 

REVĪVŌ Wellness Resort, Bali

 

REVĪVŌ is located atop the quiet hills of Nusa Dua in the south of Bali, made up of beautifully designed suites, villas and scenic grounds. It’s a holistic healing holiday with an emphasis on authentic ancient Balinese traditions. The spa boasts serene treatment rooms, contrast spa therapy plunge pools, steam rooms and a salt water floating pool. You can also focus your fitness with multi-functional facilities that include a yoga barn, a meditation room, a Pilates studio, a fitness room, and a fifty-meter lap pool. REVĪVŌ aims to soothe the spirit, rejuvenate the body and enrich the mind.

 

Health and Fitness Travel (0203 397 8891 healthandfitnesstravel.com) offers 7 nights at REVIVO from £3,355pp of £5,235 for single occupancy. Price is full board, with a wellness programme and return private transfers.

Pravassa, Worldwide

 

Offering wellness experiences in different parts of the world, embark on a wellness adventure designed to address your self-care needs. With their five-tenet wellness travel philosophy: breathe, move, mindfulness, nourish and experience, engage in immersive real-life opportunities with your idea of well-being in mind. You can travel on a custom itinerary or as part of their premium group retreats, and their wellness experts will be there to guide you throughout your journey. Have a taste of culture, wellness, luxury and a well-deserved down time so you can return home renewed and fully rejuvenated.

 

Health and Fitness Travel (0203 397 8891 healthandfitnesstravel.com) offers a 3 - 11 night Pravassa tour for £3,500pp.

 

Ayii Anargyri, Cyrpus

 

A natural healing retreat located in the west of Cyprus, Ayii Anargyri boasts an inherent atmosphere for health and restoration. Choose from a variety of programs that offer different solutions to your wellness needs, including detox, weight management, fitness, and holistic healing focusing on specific health conditions like psoriasis and arthritis. You can also easily indulge in a range of different spa treatments to leave you feeling rejuvenated and refreshed. With excellent spa and fitness facilities, Ayii Anargyri provides the right space to take some well-deserved time out for yourself to completely relax and unwind.

 

Health and Fitness Travel (0203 397 8891 healthandfitnesstravel.com) offers 7 nights at Ayii Anargyri from £1,040pp or £1,475 for single occupancy. Price is full board, with a wellness programme and return private transfers.

 

Aphrodite Hills, Cyprus

 

Wind your way up the scenic hills of Phapos and discover this idyllic 5-star golf, tennis and spa resort. With lush accommodation and an award-winning spa, Aphrodite Hills allows for an experience that truly embodies its philosophy of luxury, serenity and vitality. In between activities, replenish your energy with pampering spa treatments from hot stone massages to flower detox wraps. Explore the surrounding coastal region of Cyprus on a cycle tour during the day before you set the tone for a casual evening of alfresco dining at one of the 5 dining options to best suite your taste.

 

Health and Fitness Travel (0203 397 8891 healthandfitnesstravel.com) offers 7 nights at Aphrodite Hills from £1,105pp or £1,510 for single occupancy. Price includes breakfast, a wellness programme and return private transfers.

 

For advice, guidance and booking visit www.healthandfitnesstravel.com or call 0203 397 8891

 

GLATECT™ is now covered by five provincial drug plans

 

GLATECTTM (glatiramer acetate injection, 20 mg/1 mL) is now the only glatiramer-based treatment covered by five provincial drug plans for patients new to glatiramer acetate for the treatment of relapsing-remitting multiple sclerosis (RRMS)

  • GLATECTTM is now covered for all patients new to glatiramer acetate by the provincial drug plans in Quebec, Alberta, Saskatchewan, Manitoba and New Brunswick, based on specific criteria for the treatment of relapsing-remitting multiple sclerosis (RRMS).
  • GLATECTTM is the first subsequent glatiramer-based treatment to the original glatiramer acetate (COPAXONE®). GLATECTTM becomes the first subsequent glatiramer-based treatment in Multiple Sclerosis (MS) available for reimbursement under Canadian public drug plans.

MONTREAL, Aug. 2, 2018 /CNW Telbec/ - Provincial drug plans in five provinces have added GLATECTTM (glatiramer acetate injection, 20 mg/1 mL) to their drug formularies as the only glatiramer-based treatment covered for patients new to glatiramer acetate for the treatment of relapsing-remitting multiple sclerosis (RRMS). The most recent listings became effective on July 5th in Quebec (Exceptional Medication Status), and on July 1st in Alberta (Special Authorization Benefit) and Saskatchewan (Exception Drug Status). GLATECTTM, the first subsequent glatiramer-based treatment to the original glatiramer acetate (COPAXONE®) was launched last year by Pendopharm, a division of Pharmascience Inc.

"As leader of the MS Clinic at the Ottawa Hospital, I'm delighted that Canadian health authorities are recognizing the importance of making lower cost alternative therapies available to patients with MS," said Dr. Mark Freedman, Director of the Multiple Sclerosis (MS) Research Unit at the Ottawa Hospital. "The addition of GLATECTTM to provincial drug plans will contribute important savings to the healthcare system and to patients," added Dr. Freedman.

GLATECTTM is the first subsequent glatiramer-based treatment available for reimbursement for RRMS.1 It provides a low-cost treatment option for Canadian patients living with MS, a chronic disease of the central nervous system that is characterized by inflammation and neurodegeneration.2 Canada has one of the highest rate of MS in the world, with an estimated   77,000 Canadian adults living with the disease.2

"Multiple sclerosis disease-modifying drugs have greatly contributed to the treatment options for patients suffering from this disease," says Jean-François Lemieux, VP and General Manager of Pendopharm, a division of Pharmascience Inc.

"GLATECTTM, is a prime example of how Pendopharm, a Canadian company, contributes significantly to the sustainability of the health care system by making these therapies more accessible. We are highly optimistic to have more provinces add GLATECTTM as a covered benefit under their drug plans in the coming months." Lemieux adds.

GLATECTTM is reimbursed under specific criteria for the treatment of ambulatory patients with RRMS. Coverage criteria should be verified with each provincial health authority as it may vary.

GLATECTTM is provided in pre-filled syringes with the SENSIGO® autoinjector, a device designed to deliver daily subcutaneous doses of glatiramer to adult patients; facilitating self-injection 1, 3-4 GLATECTTM also provides Ally Patient Support Program, which offers: injection support and training, reimbursement assistance, and financial assistance.

About Pharmascience

Founded in 1983, Pharmascience Inc. is the largest pharmaceutical employer in Quebec with over 1,500 employees proudly headquartered in Montreal. Pharmascience Inc. is a full-service privately owned pharmaceutical company with strong roots in Canada and a growing global reach with product distribution in over 60 countries. Ranked 51st among Canada's top 100 Research & Development (R&D) investors with over $49 million invested in 2016, Pharmascience Inc. is the 3rd largest manufacturer of over-the-counter generic drugs in the country.

Pharmascience Inc. is a leading manufacturer and marketer of prescription generic, over-the-counter, and behind-the-counter products as well as FDA approved Canadian-made injectables. The company commercializes nearly 300 product families in 20 different dosage forms for over 2,000 products. In Canada alone, more than 45 million prescriptions a year are filled with Pharmascience products.

In 2018, the prestigious Forbes magazine ranked Pharmascience Inc. among its list of top 300 employers. Pharmascience Inc. has strong long-standing philanthropic ties with its communities, both locally and internationally. For more than 20 years, Pharmascience has been working through Health Partners International of Canada (HPIC) as a partner of choice to increase access to medicine. Pharmascience's total donations of essential medicine is close to $70 million

About Pendopharm

Pendopharm, a division of Pharmascience Inc., aims to be a new partner in the treatment of MS in Canada. Pendopharm is strategically committed to growth and is actively engaged in licensing, partnering, developing, and marketing specialty prescription medicines, as well as consumer brands. For more information, please visit www.pendopharm.com.

References: 1. Common Drug Review; Subsequent Entry Non-Biologic Complex Drug submission: glatiramer acetate (GLATECTTM). Pendopharm, a division of Pharmascience Inc. August 2017. 2. MS Society of Canada: About MS. https://mssociety.ca/about-ms. Accessed: July 23, 2018.3. GLATECT®Product Monograph. Pharmascience Inc. January 16, 2017. 4. Sensigo® Autoinjector Instructions.

 

SOURCE Pharmascience Inc.

Bumbu is back with an all-new video starring their new spokesman DJ Khaled.

The video sees DJ Khaled in a private yoga session with an instructor encouraging him to be the G.O.A.T., or “The Greatest of All Time.” As she prompts Khaled to “bring out the inner G.O.A.T.,” live goats fill the studio - one even posing atop Khaled’s shoulders! As funny as it looks, this “goat yoga” practice has become an increasingly popular trend in recent years.

Bumbu has been embracing goats as a tie-in with their tagline “The Greatest of All Time,” so goat yoga was the perfect marriage of their campaign with DJ Khaled’s permanent positivity.

DJ Khaled’s yoga mantra, “I am always progressing, I am always becoming,” means there’s always room for growth and development. “Always strive to be the G.O.A.T. in everything you do,” says Khaled. “Be the G.O.A.T. friend, the G.O.A.T. business partner, the G.O.A.T. team member, the G.O.A.T. to your significant other.”

Khaled’s Bumbu spot comes on the heels of the brand’s first G.O.A.T. video, starring Lil Wayne. It’s nice to know DJ Khaled and Lil Wayne share a love of both Bumbu and--of course--being the G.O.A.T.!

Click HERE to watch DJ Khaled doing goat yoga!

Click HERE to download the video!

About Bumbu
Bumbu is a premium, all-natural craft rum distilled, aged, and bottled in Barbados at a beachside distillery opened in 1893. The rum is an authentic recreation of a Caribbean legend, made using a 400-year old recipe for the original “Bumbu” made by sailors of the 16th and 17th century West Indies. Using sugarcane sourced from eight different countries, distilled and blended with Barbados’ naturally coral-filtered water, and aged in once-used oak bourbon barrels, Bumbu is a rum of unrivaled complexity and smoothness, and has been awarded five gold medals - including two “Best in Category” honors - in two years at the Los Angeles International Spirits Competition.

About Sovereign Brands
Sovereign Brands is a family-owned, international wine & spirits company headquartered in New York. The company is owned and operated by the Berish family and partners with first-class producers from the world's most iconic wine and spirit regions to develop superior brands. Sovereign has a portfolio of successful brands including Luc Belaire, a smash-hit line of French sparkling wines, which has earned global acclaim for its exquisite taste and striking packages, and is available in more than 100 countries around the world. The company’s portfolio also includes Bumbu, a craft rum brand from Barbados that ranks among the world’s most critically acclaimed rums, Cloud Chaser, a classic French Côtes de Provence Rosé, and Skeleton Vineyards, a range of accessible wines from Argentina and Austria.

World Fitness Expo educates and inspires with over 300 cutting-edge sessions

World famous conference and trade show presents invigorating fitness classes and high-level educational seminars
August 8-12 in Toronto

TORONTO, ON — This month, fitness enthusiasts, industry professionals and newcomers alike are getting a sneak peek at the latest trends in health and wellness at canfitpro World Fitness Expo. Attendees will get the opportunity to customize their experiences with a selection of over 300 innovative fitness, wellness and nutrition sessions, presented by over 200 industry experts. Now in its milestone 25th year, the canfitpro World Fitness Expo returns to the Metro Toronto Convention Centre August 8-12 to entertain thousands and inspire the next generation of fitness lovers.

Both experts in the field and those looking to strengthen their knowledge and routine will enjoy a wide range of workout sessions and training seminars led by exclusive celebrity talent including Jillian Michaels, Derek Hough, Tae Bo’s Billy Blanks and dancing bodybuilders, The Brutez. With hundreds of sessions from Zumba, cycling and interval training to kickboxing and ballet, there’s something for every fitness level and interest.

Calisthenics
A popular workout gaining recognition for its intense results and minimal equipment, calisthenics are predominantly bodyweight exercises intended to increase strength and flexibility through movements that use the body for resistance. Moving freely without any restrictions, calisthenics offers muscular and aerobic conditioning that improves psychomotor skills such as balance, agility and coordination. This year’s canfitpro World Fitness Expo features a calisthenics competition led by Quebec-based, Calistation.

Hot Booty Ballet
This booty-toning fitness trend is based on traditional ballet conditioning exercises that will shape, sculpt and stretch the glute muscles. Meant to increase your metabolism and burn fat to achieve optimal results, Hot Booty Ballet stands out thanks to the use of Hot Booty Bands for added resistance training. Returning to canfitpro World Fitness Expo this year, attendees can enjoy routines choreographed to match the lyrics and musicality of each song, taking this class to the next level.

YogaFit®
Founded in 1994, YogaFit is the largest yoga school in North America. Best known for its safe and inclusive approach, it focuses on the mind and body, offering classes on the safety and best practices for every individual. This year, YogaFit presents multiple sessions, including Fit and Focused Kids, a class showing how to bond with children through movement, breath, and imagery practices; and Injury Prevention and Awareness, where attendees can learn how yoga reduces the risk of injury and promotes rehabilitation and wellness.

As the largest industry conference and trade show, canfitpro World Fitness Expo aims to deliver exceptional health and fitness learning experiences and provide attendees with the skills and tools they need to take their routines beyond the gym and the classroom. Discover the full list of sessions here and the exhibitor list here. Attendees can register for sessions and purchase tickets to expo hall online at worldfitnessexpo.com.

Website: www.worldfitnessexpo.com
Twitter: @canfitpro
Instagram: @canfitpro
Facebook: @canfitpro
Hashtag: #canfitpro #worldfitnessexpo

About canfitpro
canfitpro is the largest provider of education in the Canadian fitness industry. Founded in 1993, canfitpro delivers accessible, quality education, certifications, events and membership services. canfitpro's over 24,000 members include some of the world's finest fitness professionals, health club operators, industry suppliers, and fitness consumers.

MYM Partners With Award Winning Dutch Passion for the Production and Distribution of Cannabis Seeds in Australia

 

VANCOUVER, Aug. 1, 2018 /CNW/ - MYM Nutraceuticals Inc., (CSE: MYM) (CSE: MYM.CN) (OTC: MYMMF) ("MYM") is pleased to announce it has entered into a two-year agreement with Amsterdam-based Dutch Passion for the production and distribution of Dutch Passion branded products and seed genetics in Australia.

Established in 1987 Dutch Passion is the second oldest European Cannabis seed company and for over 30 years has been a leading innovator of seed genetics. Dutch Passion has developed its own proprietary genetics and owns a seed collection of international cannabis genetics dating back to the 1970s. Since Dutch Passion was established in 1987, the company has won more than 50 Cannabis Cups for its high-THC, easy-to-grow varieties. Dutch Passion also invented feminized cannabis seeds in the 1990s and, more recently, helped pioneer the success of high-THC auto-flowering cannabis seeds.

"We are thrilled to be working with Dutch Passion in Australia. With over 30 years-experience in the development and distribution of cannabis seeds, they are considered to be world leaders," said Rob Gietl, CEO of MYM. "As legal production of cannabis has been rapidly increasing worldwide, so has the demand for seed genetics. The Dutch Passion portfolio of seeds will prove to be a very valuable asset to the shareholders of MYM."

Eric Siereveld, CEO of Dutch Passion Seed Company commented, "There were a lot of options when we were considering working with producers in Australia. We chose to partner with MYM because of their strong network and organization in the global cannabis industry. We are confident that MYM has the best environment to maximize the potential of the genetic products we offer."

Dutch Passion agreed to give MYM exclusive rights in Australia to produce and distribute under the Dutch Passion brand, all products that Dutch Passion sells currently and may sell in the future, including: clones, flowers, pre-rolled joints and other cannabis products. Australia is poised to be one of the worlds leading exporters of Cannabis products due to its favorable growing environment and low production costs. Dutch Passion also agreed to give MYM non-exclusive rights in Australia to produce and/or distribute cannabis seeds under the Dutch Passion brand.

MYM agreed to make Dutch Passion its flagship brand of cannabis seeds for sale in Australia and Dutch Passion agreed to list MYM as an official distributor of products in Australia.

About Dutch Passion

Dutch Passion is a Dutch company with over 30 years' experience in the development and distribution of cannabis seeds. Dutch Passion is focused on producing high quality, high-THC cannabis genetics and on providing attentive customer service through its experienced customer service team. Dutch Passion's diverse seed collection of international cannabis genetics dates back to the 1970s, with all varieties having passed strict tests designed to ensure ease of growth, heavy yields and high-quality results. In the 1990s, Dutch Passion invented feminized cannabis seeds and, more recently, helped to pioneer the success of high-THC auto-flowering cannabis seeds. http://www.dutch-passion.com

About MYM Nutraceuticals Inc.

MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end medicinal cannabis supplements and topical products. MYM is a shareholder in two production projects in Quebec that when completed are anticipated to have over 1.5 million square feet of production space. MYM is also a shareholder in two international cannabis production projects in Australia and Colombia. In New South Wales, Australia, the "Northern Rivers Project" is expected to have 1.2 million square feet of cannabis production space. In Medellin, Colombia, MYM and Colombia Organica have partnered and are planning to build a cannabis production facility in the region. Colombia Organica currently holds a seed to sale license for low THC cannabis which permits the company to grow, produce and create cannabis derivatives to be commercialized and / or exported. Colombia Organica is in the licensing process for the cultivation and production of high THC cannabis extracts. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE: MYM) (OTC: MYMMF) (FRA: 0MY) (DEU: 0MY) (MUN: 0MY) (STU: 0MY).

This release includes certain statements and information that constitute forward-looking information within the meaning of applicable Canadian securities laws, including statements regarding the production and distribution of Dutch Passion branded products in Australia, the anticipated access to and commercial value of Dutch Passion's list of seeds and cannabis products, the anticipated combined production space of 1.5 million square feet for the two production projects in Quebec, the anticipated 1.2 million square feet of production space in the Northern Rivers Project, and the building of a cannabis production facility in Colombia. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends," "anticipates," "it is expected," or variations of such words and phrases, or statements that certain actions, events or results "may," "could," "should," or "would" occur. Forward-looking statements are based on certain material assumptions and analyses made by the Company and the opinions and estimates of management as of the date of this press release, including the assumption that the terms and conditions of the agreements with Dutch Passion will be carried out and satisfied as anticipated, that MYM will have access to Dutch Passion's list of seeds and cannabis products and that it will be a commercially valuable asset, that the Northern Rivers Project will be completed as planned, including the construction and operation of 1.2 million square feet of production space, that MYM's projects in Quebec will be completed as planned, with 1.5 million square feet of greenhouse space, and that the cannabis production facility will be successfully built near Medellin, Colombia as anticipated by MYM. Although the Company considers these assumptions to be reasonable based on information currently available to it, they may prove to be incorrect, and the forward-looking statements in this release are subject to numerous risks, uncertainties and other factors that may cause future results to differ materially from those expressed or implied in such forward-looking statements. Such risk factors may include, among others, the risk that the terms and conditions of the agreements with Dutch Passion will not be carried out or satisfied as anticipated, or at all, that MYM will not have access to Dutch Passion's list of seeds and cannabis products due to unforeseen complications or, if it does, that such list of seeds and cannabis products will not be commercially valuable, MYM's Quebec projects will not be successfully built as planned, the Northern Rivers Project will not be successfully built as planned, the cannabis production facility will not be successfully built as planned, and the other risks and uncertainties applicable to the Company's business as set forth in the Company's management discussion and analysis and annual information form and the Company's other disclosure available under the Company's profile at http://www.sedar.com. There can be no assurance that the transactions contemplated in this news release will complete. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that is incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.
Investor Relations

SOURCE MYM Nutraceuticals Inc.

Optina Diagnostics Looks to Advance Biomarker Discovery Through Collaboration with Imagia

 

MONTREAL, Aug. 1, 2018 /CNW/ - Optina Diagnostics, a leading-edge company with a vision to revolutionize the way that Alzheimer's is diagnosed, announces today a collaborative agreement with Imagia, a Healthcare AI company whose mission is to personalize health care. Together they will be focusing on the development of retinal biomarkers for Alzheimer's disease by leveraging spectral retinal images combined with deep learning architectures to predict patient outcomes and detect disease specific markers.

The solution towards a cure for Alzheimer's begins with the early detection of the disease in order to treat it before irreversible damage occurs. Currently, the diagnosis of Alzheimer's relies on a variety of neurobehavioral tests that are subjective, as well as PET scans that are both expensive and inconvenient.

"The opportunity to work closely with the experts at Imagia Cybernectics on the discovery of spectral biomarkers for early stage, low cost, non-invasive diagnostics of Alzheimer's disease is extremely motivating," said David Lapointe, CEO at Optina Diagnostics.

"By combining our data rich images from a large number of very narrowband wavelengths with the deep learning pipelines developed by Imagia Cybernetics, we believe we can accelerate the delivery of novel biomarkers and predict patient outcomes".

"This collaboration aligns with Imagia's initiative in preventative health. Leveraging our deep radiomics platform, we aim at discovering actionable imaging biomarkers from Optina's unique spectral retinal imaging, to improve Alzheimer's patient management." said Florent Chandelier CTO at Imagia.

About Optina Diagnostics

Optina Diagnostics is a Montreal based company focused on the development of technology for the early detection of disease through hyperspectral imaging of the eye. With a first application in the early diagnosis of Alzheimer's, Optina brings a radiomics approach to biomarker detection. optinadx.com

About Imagia

Imagia Cybernetics is a Healthcare AI company, translating technology innovations into impactful patient care and experience. Our team of AI experts and clinical practitioners have purpose-built Evidens, a collaboration ecosystem that powers discovery and clinical adoption at scale — federating patient data across institutions and uniting creative minds in AI & healthcare. Together with leading pharma, imaging and interventional medical device companies, we are propelling healthcare AI products to reveal the full picture of personalized healthcare. Imagia.com

 

SOURCE Optina Diagnostics